UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Revising paediatric vancomycin dosing accounting for nephrotoxicity in a pharmacokinetic-pharmacodynamic model.

Kloprogge, F; Hill, LF; Booth, J; Klein, N; Irwin, A; Dixon, G; Standing, JF; (2019) Revising paediatric vancomycin dosing accounting for nephrotoxicity in a pharmacokinetic-pharmacodynamic model. Antimicrobial Agents and Chemotherapy 10.1128/AAC.00067-19. (In press). Green open access

[img]
Preview
Text
AAC.00067-19.full.pdf - Accepted version

Download (2MB) | Preview

Abstract

This study aimed to suggest an initial paediatric vancomycin dose regimen through population pharmacokinetic-pharmacodynamic modelling. A population pharmacokinetic approach was used to analyse vancomycin concentration-time data from a large paediatric cohort. Pharmacokinetic target attainment for patients with blood stream isolates was compared with clinical outcome using logistic regression and classification and regression trees. Change in serum creatinine during treatment was used as an indicator of acute nephrotoxicity. Probability of acute kidney injury (50% increase from baseline) or kidney failure (75% increase from baseline) was evaluated using logistic regression. An initial dosing regimen was derived, personalised by age, weight and serum creatinine using stochastic simulations. Data from 785 hospitalised paediatric patients (1 day to 21 years) with suspected Gram-positive infections were collected. Estimated (RSE) typical CL, V1, Q and V2 were (standardised to 70 kg) 4.84 (2.38) L/h, 39.9 (8.15) L, 3.85 (17.3) L/h, and 37.8 (10.2) L, respectively. Whilst cumulative vancomycin exposure correlated positively with the development of nephrotoxicity (713 patients) no clear relationship between vancomycin AUC and efficacy was found (102 patients). Predicted probability of acute kidney injury and kidney failure with the optimised dosing regimen at day 5 was 10-15% and 5-10 %, increasing by approximately 50% on day 7 and roughly 100% on day 10 across all age groups. This study presents the first data driven paediatric dose selection to-date accounting for nephrotoxicity and indicated that cumulative vancomycin exposure best described risk of acute kidney injury and acute kidney failure.

Type: Article
Title: Revising paediatric vancomycin dosing accounting for nephrotoxicity in a pharmacokinetic-pharmacodynamic model.
Open access status: An open access version is available from UCL Discovery
DOI: 10.1128/AAC.00067-19
Publisher version: https://doi.org/10.1128/AAC.00067-19
Language: English
Additional information: Copyright © 2019 Kloprogge et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.
UCL classification: UCL
UCL > Provost and Vice Provost Offices
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute for Global Health
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > UCL GOS Institute of Child Health > Infection, Immunity and Inflammation Dept
URI: https://discovery.ucl.ac.uk/id/eprint/10069812
Downloads since deposit
59Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months

Archive Staff Only

View Item View Item